S-1 capsule

DRUG2 trials

Sponsors

Zhejiang Provincial People's Hospital, Fudan University

Conditions

Esophageal CancerMetastatic Pancreatic Cancer

Phase 1

SOX-based CRT for Esophageal Cancer.

WithdrawnNCT03991104

Zhejiang Provincial People's HospitalEsophageal Cancer

Start: 2019-05-01End: 2023-12-31Updated: 2023-09-21

Phase 2

Apatinib, Irinotecan and S-1 (ApaIRIS) in Treating Patients With Metastatic Pancreatic Cancer After AG Regimen

Fudan UniversityMetastatic Pancreatic Cancer

Start: 2019-10-01End: 2021-12-31Target: 126Updated: 2019-11-05